bwxt-20240506
false000148695700014869572024-05-062024-05-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ______________________________________________________________________________
FORM 8-K
 ______________________________________________________________________________
CURRENT REPORT
 Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 6, 2024
BWX TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
 _____________________________________________________________________________
Delaware 001-34658 80-0558025
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
800 Main Street, 4th Floor
Lynchburg,Virginia24504
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (980365-4300
 ____________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueBWXTNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    



Item 2.02 Results of Operations and Financial Condition.
On May 6, 2024, we issued a press release announcing our financial results for the first quarter ended March 31, 2024.  A copy of the press release is attached as Exhibit 99.1, and the information contained in Exhibit 99.1 is incorporated by reference.
The information furnished pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d)       Exhibits
99.1
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
BWX TECHNOLOGIES, INC.
By: /s/ Mike T. Fitzgerald
 Mike T. Fitzgerald
 Vice President, Finance & Chief Accounting Officer

May 6, 2024

Document
https://cdn.kscope.io/dedec9ce29ccfe4d5dfecbb8a4b44487-erheader.jpg
BWX Technologies Reports First Quarter 2024 Results
1Q24 revenues of $604.0 million
1Q24 net income of $68.5 million, adjusted EBITDA(1) of $115.2 million
1Q24 diluted GAAP EPS of $0.75, non-GAAP(1) EPS of $0.76
Announced expansion of Cambridge manufacturing plant; enhancing capabilities to serve the global CANDU and Small Modular Reactor markets
Reaffirms 2024 non-GAAP EPS(1) guidance of $3.05-$3.20
Lynchburg, VA – May 6, 2024 - BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported first quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1.

"We started 2024 with solid operating results in each of our business segments, both financially and strategically,” said Rex. D. Geveden, president and chief executive officer. “We continued to see good organic revenue growth across our business in the first quarter with profitability tracking well given the significant onboarding of new team members and the programs we are executing to address our customers’ expanding missions.”

“BWXT’s strong employee base, technical expertise and unmatched infrastructure position us well to benefit from the increased use of nuclear technologies across global security, clean energy and medical markets,” said Geveden. “Our recent announcement to expand capacity at our Cambridge manufacturing facility not only enhances our position in the global CANDU large reactor and advanced small reactor markets, but also highlights the robust growth opportunities we see in commercial nuclear power as our customers seek to extend the life of existing power generation capacity and add new capacity with clean baseload power.”

“We are reaffirming our 2024 financial guidance and remain focused on operational excellence, innovation and providing our customers with nuclear technologies as we drive toward achieving the medium-term financial targets we provided at our recent Investor Day,” continued Geveden.


(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


Financial Results Summary
Three Months Ended March 31,
20242023$ Change% Change
(Unaudited)
(In millions, except per share amounts)
Revenues
Government Operations$487.1 $459.9 $27.2 6%
Commercial Operations$117.0 $108.9 $8.1 7%
Consolidated$604.0 $568.4 $35.6 6%
Operating Income
Government Operations$85.7 $90.6 $(4.9)(5)%
Commercial Operations$8.6 $1.5 $7.1 468%
Unallocated Corporate (Expense)$(1.3)$(4.2)$2.9 NM
Consolidated$93.0 $87.8 $5.1 6%
Consolidated non-GAAP(1)
$94.6 $91.7 $2.9 3%
EPS (Diluted)
GAAP$0.75 $0.67 $0.08 12%
Non-GAAP(1)
$0.76 $0.70 $0.06 9%
Net Income
GAAP$68.5 $61.0 $7.5 12%
Non-GAAP(1)
$69.8 $64.0 $5.7 9%
Adjusted EBITDA(1)
Government Operations$99.9 $103.6 $(3.7)(4)%
Commercial Operations$13.9 $8.9 $5.0 55%
Corporate$1.3 $(1.8)$3.2 NM
Consolidated$115.2 $110.7 $4.4 4%
Cash Flows
Operating Cash Flow(2)
$33.0 $(13.0)$46.1 NM
Capital Expenditures(2)
$30.4 $29.8 $0.6 2%
Free Cash Flow(1)
$2.6 $(42.8)$45.4 NM
Share Repurchases(2)
$20.0 $— $20.0 NM
Dividends Paid(2)
$22.4 $21.7 $0.7 3%
NM = Not Meaningful
(2) Items named in the Financial Results Summary differ from names in BWXT Financial Statement. Operating Cash Flow = Net Cash Provided by Operating Activities; Capital Expenditures = Purchases of Property, Plant and Equipment; Share Repurchases = Repurchases of Common Stock; Dividends Paid = Dividends Paid to Common Shareholders

Revenues
First quarter revenue increased in both operating segments. The Government Operations increase was driven by higher naval nuclear component production, microreactors and special materials processing, which was partially offset by lower long-lead material procurement. The Commercial Operations increase was driven by higher revenue associated with commercial nuclear field services as well as higher medical sales, which was partially offset by lower fuel handling and components volume.

Operating Income and Adjusted EBITDA(1)
First quarter operating income increased, driven by higher operating income in Commercial Operations and lower corporate expense that was partially offset by lower operating income in Government Operations. The Government Operations decrease was due to the increase in staffing levels and associated training and related inefficiencies, as well as mix due to higher microreactors revenue. The Commercial Operations
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


increase was due to improved margin in medical, but partially offset by a less favorable product mix in commercial nuclear. Additionally, corporate expense was lower, mainly due to the timing of healthcare related costs.

First quarter adjusted EBITDA(1) increased for the reasons noted above.

EPS
First quarter GAAP EPS increased due to higher operating income, higher other income, lower interest expense and a lower effective tax rate compared to first quarter 2023. Non-GAAP EPS(1) increased driven by the items noted above.

Cash Flows
First quarter operating cash flow increased due to higher net income and improved working capital management. Capital expenditures were slightly higher due to capital expenditures related to the timing of select growth investments.

Dividend
BWXT paid $22.4 million, or $0.24 per common share, to shareholders in the first quarter of 2024. On May 2, 2024, the BWXT Board of Directors declared a quarterly cash dividend of $0.24 per common share payable on June 6, 2024, to shareholders of record on May 17, 2024.
2024 Guidance
BWXT reaffirmed all components of its 2024 financial guidance.

(In millions, except per share amounts)
Year Ended
Year Ending
December 31, 2023
December 31, 2024
Results
Guidance
Revenue
$2,496
>$2,600
Adjusted EBITDA(1)
$472
~$500
Non-GAAP(1) Earnings Per Share
$3.02
$3.05 - $3.20
Free Cash Flow(1)
$212$225 - $250
Additional information can be found in the first quarter 2024 earnings call presentation on the BWXT investor relations website at www.bwxt.com/investors. The Company does not provide GAAP guidance because it is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. These items could cause GAAP results to differ materially from non-GAAP results.
Conference Call to Discuss First Quarter 2024 Results
Date: Monday, May 6, 2024, at 5:00 p.m. EDT
Live Webcast: Investor Relations section of website at www.bwxt.com
Full Earnings Release Available on BWXT Website
A full version of this earnings release is available on our Investor Relations website at http://investors.bwxt.com/1Q2024-release.
BWXT may use its website (www.bwxt.com) as a channel of distribution of material Company information. Financial and other important information regarding BWXT is routinely accessible through and posted on our website. In addition, you may elect to automatically receive e-mail alerts and other information about BWXT by enrolling through the “Email Alerts” section of our website at http://investors.bwxt.com.
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


Non-GAAP Measures
BWXT uses and makes reference to adjusted EBITDA, non-GAAP EPS, free cash flow and free cash flow conversion, which are not recognized measures under GAAP. BWXT is providing these non-GAAP measures to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations. Definitions for the non-GAAP measures are provided below and reconciliations are detailed in Exhibit 1, except that reconciliations of forward-looking GAAP measures are not provided because the company is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. Other companies may define these measures differently or may utilize different non-GAAP measures, thus impacting comparability.

Non-GAAP Earnings Per Share (EPS) is calculated using GAAP EPS less the non-operational tax effected per share impact of pension & OPEB mark-to-market gains or losses and other one-time items, such as restructuring, transformation, and acquisition-related costs.

Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) is calculated using non-GAAP net income, plus provision for income taxes, less other – net, less interest income, plus interest expense, plus depreciation and amortization.
Adjusted pre-tax income is non-GAAP income before provision for income taxes.
Free Cash Flow (FCF) is calculated using net income to derive net cash provided by (used in) operating activities less purchases of property, plant and equipment.
Free Cash Flow conversion is free cash flow divided by net income.
Non-GAAP Adjustments
Our GAAP financial results detailed in Exhibit 1 have been adjusted for the following items:
Restructuring and Transformation Costs: Restructuring and transformation related costs include restructuring charges as well as costs associated with our efforts to optimize underlying business processes through investments in information technology, process improvements and the implementation of strategic actions and initiatives which we deem to be incremental and non-recurring in nature.
Acquisition-related Costs: Acquisition-related costs relate to third-party professional service costs and one-time incremental costs associated with efforts to integrate the acquired business with our legacy operations.
Forward-Looking Statements
BWXT cautions that this release contains forward-looking statements, including, without limitation, statements relating to backlog, to the extent they may be viewed as an indicator of future revenues; our plans and expectations for each of our reportable segments, including growth opportunities and the expectations, timing and revenue of our strategic initiatives, such as medical radioisotopes, SMR components and recent acquisitions; disruptions to our supply chain and/or operations, changes in government regulations and other factors; and our expectations and guidance for 2024 and beyond. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, among other things, our ability to execute contracts in backlog; federal budget uncertainty, the risk of future budget cuts, the impact of continuing resolution funding mechanisms and the debt ceiling, the potential for government shutdowns and changing funding and acquisition priorities; the demand for and competitiveness
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


of nuclear products and services; capital priorities of power generating utilities and other customers; the timing of technology development, regulatory approvals and automation of production; the receipt and/or timing of government approvals; the potential recurrence of subsequent waves or strains of COVID-19 or similar diseases; labor market challenges, including employee retention and recruitment; adverse changes in the industries in which we operate; and delays, changes or termination of contracts in backlog. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, see BWXT’s filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2023 and subsequent Form 10-Q filings. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.
About BWXT
At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. Headquartered in Lynchburg, Virginia, BWXT is a Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental restoration, nuclear medicine and space exploration. With more than 7,800 employees, BWXT has 14 major operating sites in the U.S., Canada and the U.K. In addition, BWXT joint ventures provide management and operations at a dozen U.S. Department of Energy and NASA facilities. For more information, visit www.bwxt.com. Follow us on LinkedIn, X, Facebook and Instagram.

Investor Contact:Media Contact:
Chase JacobsonJud Simmons
Vice President, Investor RelationsSenior Director, Media and Public Relations
980-365-4300Investors@bwxt.com434-522-6462hjsimmons@bwxt.com

(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


EXHIBIT 1
BWX TECHNOLOGIES, INC.
RECONCILIATION OF NON-GAAP OPERATING INCOME AND EARNINGS PER SHARE(1)(2)(3)
(In millions, except per share amounts)
Three Months Ended March 31, 2024
 GAAPRestructuring & Transformation CostsAcquisition-related CostsNon-GAAP
   
Operating Income$93.0 $1.6 $0.1 $94.6 
Other Income (Expense)(4.6)— — (4.6)
Income Before Provision for Income Taxes88.4 1.6 0.1 90.0 
Provision for Income Taxes(19.8)(0.4)(0.0)(20.2)
Net Income68.5 1.2 0.0 69.8 
Net Income Attributable to Noncontrolling Interest
(0.1)— — (0.1)
Net Income Attributable to BWXT
$68.5 $1.2 $0.0 $69.7 
 
Diluted Shares Outstanding91.9 91.9 
Diluted Earnings per Common Share
$0.75 $0.01 $0.00 $0.76 
Effective Tax Rate22.5%22.5%
Government Operations Operating Income$85.7 $— $— $85.7 
Commercial Operations Operating Income$8.6 $0.9 $— $9.4 
Unallocated Corporate Operating Income$(1.3)$0.7 $0.1 $(0.5)
Three Months Ended March 31, 2023
 GAAPRestructuring CostsAcquisition-related CostsNon-GAAP
   
Operating Income$87.8 $3.5 $0.3 $91.7 
Other Income (Expense)(8.2)— — (8.2)
Income Before Provision for Income Taxes79.7 3.5 0.3 83.5 
Provision for Income Taxes(18.7)(0.7)(0.1)(19.5)
Net Income61.0 2.8 0.3 64.0 
Net Income Attributable to Noncontrolling Interest
0.1 — — 0.1 
Net Income Attributable to BWXT
$61.1 $2.8 $0.3 $64.1 
 
Diluted Shares Outstanding91.8 91.8 
Diluted Earnings per Common Share
$0.67 $0.03 $0.00 $0.70 
Effective Tax Rate23.4%23.3%
Government Operations Operating Income$90.6 $— $0.3 $90.8 
Commercial Operations Operating Income$1.5 $3.1 $— $4.6 
Unallocated Corporate Operating Income$(4.2)$0.4 $0.1 $(3.7)


(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


EXHIBIT 1 (continued)
RECONCILIATION OF CONSOLIDATED ADJUSTED EBITDA(1)(2)(3)
(In millions)

Three Months Ended March 31, 2024
 GAAPRestructuring & Transformation CostsAcquisition-related CostsNon-GAAP
 
Net Income$68.5 $1.2 $0.0 $69.8 
Provision for Income Taxes19.8 0.4 0.0 20.2 
Other – net(4.2)— — (4.2)
Interest Expense9.6 — — 9.6 
Interest Income(0.8)— — (0.8)
Depreciation & Amortization20.6 — — 20.6 
Adjusted EBITDA$113.5 $1.6 $0.1 $115.2 
Three Months Ended March 31, 2023
 GAAPRestructuring CostsAcquisition-related CostsNon-GAAP
 
Net Income$61.0 $2.8 $0.3 $64.0 
Provision for Income Taxes18.7 0.7 0.1 19.5 
Other – net(2.2)— — (2.2)
Interest Expense10.8 — — 10.8 
Interest Income(0.5)— — (0.5)
Depreciation & Amortization19.0 — — 19.0 
Adjusted EBITDA$106.9 $3.5 $0.3 $110.7 
RECONCILIATION OF REPORTING SEGMENT ADJUSTED EBITDA(1)(2)(3)
(In millions)
Three Months Ended March 31, 2024
 Operating Income (GAAP)
Non-GAAP Adjustments(4)
Depreciation & AmortizationAdjusted EBITDA
 
Government Operations$85.7 $— $14.2 $99.9 
Commercial Operations$8.6 $0.9 $4.4 $13.9 
Three Months Ended March 31, 2023
 Operating Income (GAAP)
Non-GAAP Adjustments(4)
Depreciation & AmortizationAdjusted EBITDA
 
Government Operations$90.6 $0.3 $12.8 $103.6 
Commercial Operations$1.5 $3.1 $4.4 $8.9 

(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


EXHIBIT 1 (continued)
RECONCILIATION OF CONSOLIDATED FREE CASH FLOW(1)(2)(3)
(In millions)
Three Months Ended March 31, 2024
 
Net Cash Provided By Operating Activities$33.0 
Purchases of Property, Plant and Equipment(30.4)
Free Cash Flow$2.6 
Three Months Ended March 31, 2023
 
Net Cash Used In Operating Activities$(13.0)
Purchases of Property, Plant and Equipment(29.8)
Free Cash Flow$(42.8)
(1)
Tables may not foot due to rounding.
(2)BWXT is providing non-GAAP information regarding certain of its historical results and guidance on future earnings per share to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations.
(3)BWXT has not included a reconciliation of provided non-GAAP guidance to the comparable GAAP measures due to the difficulty of estimating any mark-to-market adjustments for pension and post-retirement benefits, which are determined at the end of the year.
(4)For Non-GAAP adjustment details, see reconciliation of non-GAAP operating income and earnings per share.
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended March 31,
20242023
(Unaudited)
(In thousands, except share and per share amounts)
Revenues$603,966 $568,360 
Costs and Expenses:
Cost of operations455,357 431,130 
Research and development costs1,490 2,204 
Losses (gains) on asset disposals and impairments, net— (6)
Selling, general and administrative expenses67,361 60,835 
Total Costs and Expenses524,208 494,163 
Equity in Income of Investees13,203 13,645 
Operating Income92,961 87,842 
Other Income (Expense):
Interest income846 463 
Interest expense(9,595)(10,819)
Other – net4,165 2,188 
Total Other Income (Expense)(4,584)(8,168)
Income before Provision for Income Taxes
88,377 79,674 
Provision for Income Taxes19,843 18,681 
Net Income$68,534 $60,993 
Net Loss (Income) Attributable to Noncontrolling Interest(66)99 
Net Income Attributable to BWX Technologies, Inc.$68,468 $61,092 
Earnings per Common Share:
Basic:
Net Income Attributable to BWX Technologies, Inc.$0.75 $0.67 
Diluted:
Net Income Attributable to BWX Technologies, Inc.$0.75 $0.67 
Shares used in the computation of earnings per share:
Basic91,555,384 91,503,988 
Diluted91,860,923 91,799,690 
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended March 31,
20242023
(Unaudited) (In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income$68,534 $60,993 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization20,552 19,020 
Income of investees, net of dividends(2,400)(5,855)
Recognition of losses for pension and postretirement plans831 830 
Stock-based compensation expense4,297 3,893 
Other, net129 495 
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable(15,493)(4,268)
Accounts payable32,832 8,135 
Retainages(26,325)(33,276)
Contracts in progress and advance billings on contracts(17,174)(27,471)
Income taxes17,820 3,096 
Accrued and other current liabilities(2,025)(9,315)
Pension liabilities, accrued postretirement benefit obligations and employee benefits(27,687)(23,097)
Other, net(20,865)(6,204)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES33,026 (13,024)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment(30,422)(29,780)
Purchases of securities— (1,431)
Sales and maturities of securities— 1,425 
Other, net99 
NET CASH USED IN INVESTING ACTIVITIES(30,323)(29,780)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings of long-term debt120,700 127,000 
Repayments of long-term debt(102,263)(48,563)
Repurchases of common stock(20,000)— 
Dividends paid to common shareholders(22,396)(21,667)
Cash paid for shares withheld to satisfy employee taxes(6,907)(6,903)
Settlements of forward contracts, net(1,337)(535)
Other, net47 
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES(32,156)49,336 
EFFECTS OF EXCHANGE RATE CHANGES ON CASH(171)
TOTAL (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS(29,624)6,539 
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD81,615 40,990 
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT END OF PERIOD$51,991 $47,529 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest$15,461 $8,174 
Income taxes (net of refunds)$2,161 $15,474 
SCHEDULE OF NON-CASH INVESTING ACTIVITY:
Accrued capital expenditures included in accounts payable$6,612 $11,824 
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

ASSETS
March 31,
2024
December 31,
2023
(Unaudited)
(In thousands)
Current Assets:
Cash and cash equivalents$45,895 $75,766 
Restricted cash and cash equivalents2,892 2,858 
Accounts receivable – trade, net85,024 70,180 
Accounts receivable – other12,842 16,339 
Retainages81,506 55,181 
Contracts in progress550,089 533,155 
Other current assets86,415 64,322 
Total Current Assets864,663 817,801 
Property, Plant and Equipment, Net1,231,473 1,228,520 
Investments10,034 9,496 
Goodwill294,339 297,020 
Deferred Income Taxes14,828 16,332 
Investments in Unconsolidated Affiliates91,008 88,608 
Intangible Assets180,084 185,510 
Other Assets101,581 103,778 
TOTAL$2,788,010 $2,747,065 

(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS' EQUITY
March 31,
2024
December 31,
2023
(Unaudited)
(In thousands, except share
and per share amounts)
Current Liabilities:
Current portion of long-term debt$7,813 $6,250 
Accounts payable147,841 126,651 
Accrued employee benefits40,093 64,544 
Accrued liabilities – other78,717 70,210 
Advance billings on contracts112,361 107,391 
Total Current Liabilities386,825 375,046 
Long-Term Debt1,220,809 1,203,422 
Accumulated Postretirement Benefit Obligation18,022 18,466 
Environmental Liabilities92,221 90,575 
Pension Liability79,557 82,786 
Other Liabilities44,510 43,469 
Commitments and Contingencies
Stockholders' Equity:
Common stock, par value $0.01 per share, authorized 325,000,000 shares; issued 128,272,806 and 128,065,521 shares at March 31, 2024 and December 31, 2023, respectively1,283 1,281 
Preferred stock, par value $0.01 per share, authorized 75,000,000 shares; No shares issued— — 
Capital in excess of par value210,991 206,478 
Retained earnings2,140,235 2,093,917 
Treasury stock at cost, 36,864,580 and 36,537,695 shares at March 31, 2024 and December 31, 2023, respectively(1,387,768)(1,360,862)
Accumulated other comprehensive income (loss)(18,519)(7,463)
Stockholders' Equity – BWX Technologies, Inc.946,222 933,351 
Noncontrolling interest(156)(50)
Total Stockholders' Equity946,066 933,301 
TOTAL$2,788,010 $2,747,065 
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.


BWX TECHNOLOGIES, INC.
BUSINESS SEGMENT INFORMATION
Three Months Ended March 31,
20242023
(Unaudited)
(In thousands)
REVENUES:
Government Operations$487,121 $459,886 
Commercial Operations117,038 108,924 
Eliminations(193)(450)
TOTAL$603,966 $568,360 
 
SEGMENT INCOME:
Government Operations$85,686 $90,560 
Commercial Operations8,591 1,513 
SUBTOTAL$94,277 $92,073 
Unallocated Corporate(1,316)(4,231)
TOTAL$92,961 $87,842 
 
DEPRECIATION AND AMORTIZATION:
Government Operations$14,234 $12,795 
Commercial Operations4,444 4,359 
Corporate1,874 1,866 
TOTAL$20,552 $19,020 
 
CAPITAL EXPENDITURES:
Government Operations$16,383 $15,268 
Commercial Operations13,344 13,951 
Corporate695 561 
TOTAL$30,422 $29,780 
BACKLOG:
Government Operations$2,908,986 $3,108,628 
Commercial Operations726,523 665,745 
TOTAL$3,635,509 $3,774,373 
BOOKINGS:
Government Operations$179,413 $52,737 
Commercial Operations62,414 145,686 
TOTAL$241,827 $198,423 
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.